Pfizer Inc.
PFE
$43.38
-$0.3799-0.87%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 10/02/2022 | 07/03/2022 | 04/03/2022 | 12/31/2021 | 10/03/2021 | |
|---|---|---|---|---|---|
| Revenue | 22.64B | 27.74B | 25.66B | 23.64B | 24.04B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.64B | 27.74B | 25.66B | 23.64B | 24.04B |
| Cost of Revenue | 6.04B | 8.17B | 9.95B | 9.57B | 9.90B |
| Gross Profit | 16.60B | 19.57B | 15.71B | 14.07B | 14.14B |
| SG&A Expenses | 2.93B | 3.20B | 2.22B | 2.83B | 1.66B |
| Depreciation & Amortization | 822.00M | 822.00M | 835.00M | 916.00M | 968.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.49B | 15.00B | 15.31B | 16.81B | 15.21B |
| Operating Income | 10.15B | 12.74B | 10.35B | 6.83B | 8.83B |
| Income Before Tax | 9.00B | 11.45B | 9.05B | 4.18B | 7.84B |
| Income Tax Expenses | 356.00M | 1.57B | 1.17B | 334.00M | -328.00M |
| Earnings from Continuing Operations | 8.64B | 9.88B | 7.88B | 3.85B | 8.17B |
| Earnings from Discontinued Operations | -21.00M | 34.00M | -9.00M | -458.00M | -13.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -6.00M | -6.00M | 2.00M | -12.00M |
| Net Income | 8.61B | 9.91B | 7.86B | 3.39B | 8.15B |
| EBIT | 10.15B | 12.74B | 10.35B | 6.83B | 8.83B |
| EBITDA | 11.33B | 13.91B | 11.53B | 8.11B | 10.14B |
| EPS Basic | 1.54 | 1.77 | 1.40 | 0.60 | 1.45 |
| Normalized Basic EPS | 1.17 | 1.43 | 1.17 | 0.76 | 1.01 |
| EPS Diluted | 1.51 | 1.74 | 1.37 | 0.59 | 1.43 |
| Normalized Diluted EPS | 1.15 | 1.40 | 1.14 | 0.74 | 0.99 |
| Average Basic Shares Outstanding | 5.61B | 5.59B | 5.62B | 5.62B | 5.61B |
| Average Diluted Shares Outstanding | 5.72B | 5.71B | 5.76B | 5.77B | 5.73B |
| Dividend Per Share | 0.40 | 0.40 | 0.40 | 0.39 | 0.39 |
| Payout Ratio | 26.08% | -- | 28.60% | 64.52% | 26.82% |
